Chase Science Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Chase Science için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Electronic kazanç büyümesi	32.3%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Chase Science's (SZSE:300941) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 05

Chase Science Co., Ltd (SZSE:300941) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Sep 30

Chase Science's (SZSE:300941) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 17

Investors Could Be Concerned With Chase Science's (SZSE:300941) Returns On Capital

Jun 08

More Unpleasant Surprises Could Be In Store For Chase Science Co., Ltd's (SZSE:300941) Shares After Tumbling 25%

Apr 21

What Chase Science Co., Ltd's (SZSE:300941) 26% Share Price Gain Is Not Telling You

Mar 04

Returns On Capital Signal Tricky Times Ahead For Chase Science (SZSE:300941)

Feb 27

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Chase Science yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

SZSE:300941 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (CNY Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2024	257	76	39	39	N/A
6/30/2024	254	75	13	14	N/A
3/31/2024	256	81	47	48	N/A
12/31/2023	261	81	-2	-1	N/A
9/30/2023	321	91	36	38	N/A
6/30/2023	344	96	77	79	N/A
3/31/2023	384	109	82	84	N/A
1/1/2023	395	111	89	90	N/A
9/30/2022	381	108	112	114	N/A
6/30/2022	395	109	108	110	N/A
3/31/2022	402	107	134	136	N/A
1/1/2022	420	106	101	102	N/A
9/30/2021	524	127	116	117	N/A
6/30/2021	567	137	128	130	N/A
3/31/2021	629	148	150	152	N/A
12/31/2020	614	146	155	157	N/A
9/30/2020	625	137	128	130	N/A
6/30/2020	605	123	148	149	N/A
3/31/2020	527	106	59	61	N/A
12/31/2019	542	100	107	109	N/A
9/30/2019	496	77	49	51	N/A
6/30/2019	474	75	50	51	N/A
3/31/2019	463	69	68	69	N/A
1/1/2019	407	67	44	44	N/A
9/30/2018	391	63	40	42	N/A
6/30/2018	350	59	N/A	-21	N/A
3/31/2018	318	59	N/A	-7	N/A
12/31/2017	307	55	N/A	56	N/A
9/30/2017	142	36	N/A	-20	N/A
6/30/2017	161	47	N/A	40	N/A
3/31/2017	142	42	N/A	50	N/A
12/31/2016	147	44	N/A	51	N/A
9/30/2016	134	41	N/A	42	N/A
6/30/2016	135	41	N/A	33	N/A
3/31/2016	129	37	N/A	29	N/A
1/1/2016	115	31	N/A	24	N/A
9/30/2015	123	29	N/A	22	N/A
6/30/2015	123	25	N/A	21	N/A
3/31/2015	128	24	N/A	13	N/A
1/1/2015	133	24	N/A	5	N/A
12/31/2013	161	16	N/A	13	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 300941 'un tahmini kazanç büyümesinin tasarruf oranının ( 2.8% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: 300941 'un kazançlarının CN pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: 300941 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: 300941 şirketinin gelirinin CN pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: 300941 şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 300941 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Chase Science Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Investor sentiment improves as stock rises 16%

Chase Science's (SZSE:300941) Weak Earnings May Only Reveal A Part Of The Whole Picture

Third quarter 2024 earnings released: EPS: CN¥0.051 (vs CN¥0.049 in 3Q 2023)

Chase Science Co., Ltd Announces Interim Cash Dividend of the Year 2024 of A Shares, Payable on 17 October 2024

Chase Science Co., Ltd (SZSE:300941) Stock Rockets 41% As Investors Are Less Pessimistic Than Expected

Chase Science Co., Ltd to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 18%

New major risk - Earnings quality

New major risk - Share price stability

Investor sentiment improves as stock rises 20%

Second quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.043 in 2Q 2023)

Investor sentiment deteriorates as stock falls 17%

Chase Science Co., Ltd to Report First Half, 2024 Results on Aug 28, 2024

Chase Science's (SZSE:300941) Shareholders Will Receive A Smaller Dividend Than Last Year

Dividend reduced to CN¥0.14

Investors Could Be Concerned With Chase Science's (SZSE:300941) Returns On Capital

Chase Science Co., Ltd, Annual General Meeting, May 17, 2024

Chase Science Co., Ltd Proposes Final Cash Dividend for the Year 2023

First quarter 2024 earnings released: EPS: CN¥0.07 (vs CN¥0.08 in 1Q 2023)

More Unpleasant Surprises Could Be In Store For Chase Science Co., Ltd's (SZSE:300941) Shares After Tumbling 25%

Investor sentiment deteriorates as stock falls 18%

Insufficient new directors

Chase Science Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024

Investor sentiment deteriorates as stock falls 16%

What Chase Science Co., Ltd's (SZSE:300941) 26% Share Price Gain Is Not Telling You

Returns On Capital Signal Tricky Times Ahead For Chase Science (SZSE:300941)

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 18%

Chase Science Co., Ltd to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.049 (vs CN¥0.069 in 3Q 2022)

Investor sentiment deteriorates as stock falls 18%

Chase Science Co., Ltd to Report Q3, 2023 Results on Oct 27, 2023

Second quarter 2023 earnings released: EPS: CN¥0.043 (vs CN¥0.11 in 2Q 2022)

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

Chase Science Co., Ltd. Implements Final Cash Dividend of A Shares for the Year 2022, Payable on June 8, 2023

Chase Science Co., Ltd. Approves the Cash Dividend for the Year 2022

First quarter 2023 earnings released: EPS: CN¥0.08 (vs CN¥0.08 in 1Q 2022)

Investor sentiment deteriorates as stock falls 15%

Chase Science Co., Ltd. (SZSE:300941) announces an Equity Buyback for CNY 50 million worth of its shares.

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.069 (vs CN¥0.074 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.12 in 2Q 2021)

Chase Science Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 9, 2022

Chase Science Co., Ltd. Approves Cash Dividend for the Year 2021

Chase Science Co., Ltd. Announces Profit Distribution Proposal for 2021

First quarter 2022 earnings released: EPS: CN¥0.12 (vs CN¥0.12 in 1Q 2021)

High number of new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.25 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.31 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Chase Science Co., Ltd. Approves Cash Dividend for the Year 2020

Investor sentiment deteriorated over the past week

Chase Science Co., Ltd. Proposes Final Dividend

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Chase Science Co., Ltd. Approves Executive Changes

Kazanç ve Gelir Büyüme Tahminleri

Analist Gelecek Büyüme Tahminleri

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Büyüyen şirketleri keşfedin